` HTFL (Heartflow Inc) vs S&P 500 Comparison - Alpha Spread

H
HTFL
vs
S&P 500

Over the past 12 months, HTFL has significantly outperformed S&P 500, delivering a return of +45% compared to S&P 500's +11% growth.

Stocks Performance
HTFL vs S&P 500

Loading...
HTFL
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HTFL vs S&P 500

Performance Gap Between HTFL and GSPC
LOCKED
Unlock

Performance By Year
HTFL vs S&P 500

Loading...
HTFL
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Heartflow Inc vs Peers

S&P 500
HTFL
VEEV
PME
2413
SECT B
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Heartflow Inc
Glance View

Market Cap
4.8B USD
Industry
Health Care

Heartflow is a medical technology company that helps doctors look for coronary artery disease using heart CT scans. Its core product is software that turns a standard coronary CT angiogram into a detailed 3D model of the patient’s arteries and gives doctors more information about blood flow and plaque. Instead of building devices or drugs, Heartflow sells analysis services and software that sit between the imaging scan and the treatment decision. Its main customers are hospitals, cardiology practices, imaging centers, and health systems that diagnose patients with chest pain or suspected heart disease. These customers use Heartflow’s reports to decide whether a patient needs medicine, more testing, or an invasive procedure. The company makes money by charging for each analysis or through contract-based access to its software and services. What makes Heartflow different is that it turns a routine, noninvasive scan into a decision-making tool for cardiologists. It is part of the diagnostic workflow, not the treatment side of the business, so its value depends on being useful to doctors, easy to fit into hospital systems, and trusted in clinical care.

HTFL Intrinsic Value
LOCKED
Unlock
Back to Top